Key regions: United Kingdom, Canada, Japan, Europe, China
Egypt is a country known for its ancient civilization and rich history, but it is also a country that is experiencing growth in its dermatological drugs market. With a population of over 100 million people, there is a high demand for skincare products and treatments to combat various skin conditions.
Customer preferences: Egyptian consumers are becoming more aware of the importance of skincare and are increasingly seeking out dermatological drugs to treat their skin conditions. The preference for natural and organic products is also on the rise, with many consumers looking for products that are free from harmful chemicals.
Trends in the market: One of the main trends in the Egyptian dermatological drugs market is the increasing demand for anti-aging products. As the population ages, there is a growing need for products that can help to reduce the signs of aging and improve skin elasticity. Another trend is the rising popularity of acne treatments, with many consumers looking for effective solutions to combat this common skin condition.
Local special circumstances: Egypt has a hot and dry climate, which can cause a number of skin problems such as dryness, sun damage, and hyperpigmentation. This has led to a high demand for moisturizing and sun protection products, as well as products that can help to even out skin tone.
Underlying macroeconomic factors: The Egyptian economy has been steadily growing in recent years, which has led to an increase in disposable income and consumer spending. This has allowed more consumers to afford dermatological drugs and other skincare products. In addition, the government has been investing in the healthcare sector, which has helped to improve access to healthcare services and products, including dermatological drugs.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
